Dothan, David
Raisin, Galiya
Malchi, Nadav
Gordon, Avi
Touitou, Dan
Chertin, Boris https://orcid.org/0000-0002-8347-0969
Article History
Received: 7 March 2022
Accepted: 1 June 2022
First Online: 3 July 2022
Declarations
:
: David Dothan, Galiya Raisin and Boris Chertin—None of the authors has a conflict of interest to declare. Nadav Malchi, Avi Gordon, Dan Touitou are employers of TRIGON Pharma, which developed TRG-042.